4.7 Article

The Proteasome in Modern Drug Discovery: Second Life of a Highly Valuable Drug Target

期刊

ACS CENTRAL SCIENCE
卷 3, 期 8, 页码 830-838

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acscentsci.7b00252

关键词

-

资金

  1. Alexander von Humboldt Foundation
  2. US National Institutes of Health [R35CA197589]

向作者/读者索取更多资源

As the central figure of the cellular protein degradation machinery, the proteasome is critical for cell survival. Having been extensively targeted for inhibition, the constitutive proteasome has proven its role as a highly valuable drug target. However, recent advances in the protein homeostasis field suggest that additional chapters can be added to this successful story. For example, selective immunoproteasome inhibition promises high clinical efficacy for autoimmune disorders and inflammation, and proteasome inhibitors might serve as novel therapeutics for malaria or other microorganisms. Furthermore, utilizing the destructive force of the proteasome for selective degradation of essential drivers of human disorders has opened up a new and exciting area of drug discovery. Thus, the field of proteasome drug discovery still holds exciting questions to be answered and does not simply end with inhibiting the constitutive proteasome.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据